Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of genetic polymorphisms in risk assessment of drugs.

Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement - 1 Jan 1994

Poulsen H E, Loft S

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arylamine N-Acetyltransferase
Share to Cytochrome P-450 Enzyme System
Share to Drug-Related Side Effects and Adverse Reactions
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pharmaceutical Preparations

Share to Polymorphism, Genetic

Share to Risk Factors

Source

Identifiers

PMID: 8192584
DOI: 10.1007/978-3-642-78640-2_24

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of genetic polymorphisms in risk assessment of drugs.PMID 8192584Read ↗

Genetic polymorphisms of drug metabolism.Semantic proximity Read ↗

The Value of Clinical Pharmacogenomic Guidelines That Recommend Standard of Care Over Genotype-Based Prescribing.Semantic proximity Read ↗

What Will Be the Role of Pharmacogenetics in Evaluating Drug Safety and Minimising Adverse Effects?Semantic proximity Read ↗

Meaningful use of pharmacogenetics.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: using genetic information to guide therapeutic decision making.Semantic proximity Read ↗

Pharmacogenetic analysis of clinically relevant genetic polymorphisms.Semantic proximity Read ↗

Genetic variation as a guide to drug development.Semantic proximity Read ↗

Genetic Risk Factors for Adverse Drug ReactionsSemantic proximity Read ↗

Role of pharmacogenetics in public health and clinical health care: a SWOT analysisSemantic proximity Read ↗

How to Consider Rare Genetic Variants in Personalized Drug Therapy.Semantic proximity Read ↗

Overview of pharmacogenetics.Semantic proximity Read ↗

Impact of Pharmacogenomics in Clinical PracticeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.